Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL151858)
University of Houston (I0503554)
Received: 2 March 2022
Accepted: 14 July 2022
First Online: 13 August 2022
: SSS is an inventor on U.S. Patent #9,789,235 “Separation and concentration of particles” describing the controlled incremental filtration technology, and part-owner of Halcyon Biomedical Incorporated, a company that would benefit from its commercialization. All other authors declare no conflict of interest.